Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease
Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):466-471.
doi: 10.1016/j.rec.2021.11.024.
Epub 2022 Apr 12.
[Article in
English,
Spanish]
Collaborators
-
SEC Working Group for the 2021 ESC/EACTS guidelines for the management of valvular heart disease and SEC Guidelines Committee:
Pablo Avanzas, Javier Bermejo, Manuel Barreiro-Pérez, Belén Cid, Victoria Delgado, J Alberto San Román, Arturo Evangelista, Pastora Gallego, Francisco Javier García Aranda, José López-Menéndez, Marta Sitges, Isidre Vilacosta, Pablo Avanzas, Gemma Berga Congost, Araceli Boraita, Héctor Bueno, David Calvo, Raquel Campuzano, Victoria Delgado, Laura Dos, Ignacio Ferreira-Gonzalez, Juan José Gomez Doblas, Domingo Pascual Figal, Antonia Sambola, Ana Viana Tejedor, José Luis Ferreiro, Fernando Alfonso
No abstract available
MeSH terms
-
Heart Valve Diseases* / diagnosis
-
Heart Valve Diseases* / surgery
-
Heart Valve Prosthesis Implantation*
-
Humans